| ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers J Garousi, S Lindbo, J Nilvebrant, M Åstrand, J Buijs, M Sandström, ... Cancer research 75 (20), 4364-4371, 2015 | 80 | 2015 |
| Tailored doxorubicin‐H yaluronan conjugate as a potent anticancer glyco‐D rug: an alternative to prodrug approach OP Oommen, J Garousi, M Sloff, OP Varghese Macromolecular bioscience 14 (3), 327-333, 2014 | 78 | 2014 |
| Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer O Bragina, E von Witting, J Garousi, R Zelchan, M Sandström, A Orlova, ... Journal of nuclear medicine 62 (4), 493-499, 2021 | 74 | 2021 |
| Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3 A Vorobyeva, A Schulga, E Konovalova, R Güler, J Löfblom, M Sandström, ... Scientific Reports 9 (1), 9405, 2019 | 62 | 2019 |
| PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules J Garousi, KG Andersson, B Mitran, ML Pichl, S Ståhl, A Orlova, J Löfblom, ... International journal of oncology 48 (4), 1325-1332, 2016 | 59 | 2016 |
| Influence of histidine-containing tags on the biodistribution of ADAPT scaffold proteins S Lindbo, J Garousi, M Åstrand, H Honarvar, A Orlova, S Hober, ... Bioconjugate chemistry 27 (3), 716-726, 2016 | 53 | 2016 |
| Comparative evaluation of two DARPin variants: effect of affinity, size, and label on tumor targeting properties S Deyev, A Vorobyeva, A Schulga, G Proshkina, R Guler, J Lofblom, ... Molecular pharmaceutics 16 (3), 995-1008, 2019 | 50 | 2019 |
| Imaging using radiolabelled targeted proteins: Radioimmunodetection and beyond J Garousi, A Orlova, FY Frejd, V Tolmachev EJNMMI radiopharmacy and chemistry 5, 1-26, 2020 | 48 | 2020 |
| Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label S Lindbo, J Garousi, B Mitran, M Altai, J Buijs, A Orlova, S Hober, ... Journal of Nuclear Medicine 59 (1), 93-99, 2018 | 42 | 2018 |
| Comparative evaluation of affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX J Garousi, H Honarvar, KG Andersson, B Mitran, A Orlova, J Buijs, ... Molecular pharmaceutics 13 (11), 3676-3687, 2016 | 41 | 2016 |
| Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression D Summer, J Garousi, M Oroujeni, B Mitran, KG Andersson, A Vorobyeva, ... Molecular pharmaceutics 15 (1), 175-185, 2018 | 36 | 2018 |
| The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule J Garousi, KG Andersson, JH Dam, BB Olsen, B Mitran, A Orlova, J Buijs, ... Scientific Reports 7 (1), 5961, 2017 | 35 | 2017 |
| Characterization of pure and antimony doped SnO2 thin films prepared by the sol-gel technique AAJ NOVINROUZ, P Sarabadani, J Garousi IRANIAN JOURNAL OF CHEMISTRY AND CHEMICAL ENGINEERING (IJCCE) 25 (2), 32-38, 2006 | 35 | 2006 |
| Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 affibody molecule H HONARvAR, J Garousi, E Gunneriusson, I HöIDéN-GUTHENbERG, ... International journal of oncology 46 (2), 513-520, 2015 | 34 | 2015 |
| Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours J Garousi, S Lindbo, J Borin, E von Witting, A Vorobyeva, M Oroujeni, ... European journal of pharmaceutics and biopharmaceutics 134, 37-48, 2019 | 32 | 2019 |
| Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator KG Andersson, M Oroujeni, J Garousi, B Mitran, S Ståhl, A Orlova, ... International journal of oncology 49 (6), 2285-2293, 2016 | 32 | 2016 |
| Comparison of tumor‑targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2 A Vorobyeva, A Sсhulga, E Konovalova, R Güler, B Mitran, J Garousi, ... International journal of oncology 54 (4), 1209-1220, 2019 | 30 | 2019 |
| Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1 SM Deyev, A Vorobyeva, A Schulga, A Abouzayed, T Günther, J Garousi, ... International journal of biological macromolecules 145, 216-225, 2020 | 27 | 2020 |
| Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6 E von Witting, J Garousi, S Lindbo, A Vorobyeva, M Altai, M Oroujeni, ... European journal of pharmaceutics and biopharmaceutics 140, 109-120, 2019 | 27 | 2019 |
| Preparation, quality control and biodistribution studies of two [111In]-rituximab immunoconjugates AR Jalilian, D Sardari, L Kia, P Rowshanfarzad, J Garousi, M Akhlaghi, ... Scientia pharmaceutica 76 (2), 151-170, 2008 | 26 | 2008 |
